Inventor
JIANG CONG
US24 patents
⚠️ This page may combine multiple inventors who share the name “JIANG CONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HILL ROM SERVICES PTE LTD
10 patentsUS10905837B2Feb 2, 2021
Respiratory therapy cycle control and feedback
HILL ROM SERVICES PTE LTD7 citations82
USD862643SOct 8, 2019
Flow control apparatus
HILL ROM SERVICES PTE LTD5 citations82
US10987264B2Apr 27, 2021
Combination respiratory therapy and mattress functionality system integrated into a patient bed
HILL ROM SERVICES PTE LTD6 citations81
US10905836B2Feb 2, 2021
Manifold for respiratory device
HILL ROM SERVICES PTE LTD7 citations81
US11992611B2May 28, 2024
Respiratory therapy apparatus control
HILL ROM SERVICES PTE LTD1 citations71
USD877859SMar 10, 2020
Flow control apparatus
HILL ROM SERVICES PTE LTD1 citations71
US11529275B2Dec 20, 2022
Combination respiratory therapy and mattress functionality system integrated into a patient bed
HILL ROM SERVICES PTE LTD2 citations70
US11452824B2Sep 27, 2022
Respiratory therapy filter, flow control, and patient interface apparatuses, systems, and methods
HILL ROM SERVICES PTE LTD2 citations69
US12465704B2Nov 11, 2025
Manifold for respiratory therapy apparatus
HILL ROM SERVICES PTE LTD0 citations60
US12544521B2Feb 10, 2026
Respiratory therapy filter, flow control, and patient interface apparatuses, systems, and methods
HILL ROM SERVICES PTE LTD0 citations59
BAXTER INT
5 patentsUSRE47452EJun 25, 2019
Antimicrobial housing and cover for a medical device
BAXTER INT2 citations71
US9574060B2Feb 21, 2017
Antimicrobial housing and cover for a medical device
BAXTER INT2 citations71
US7384558B2Jun 10, 2008
Compositions capable of inhibiting reactive oxygen and carbonyl species
BAXTER INT2 citations59
US9511053B2Dec 6, 2016
Nitric oxide scavengers
BAXTER INT0 citations50
US8962549B2Feb 24, 2015
Polymeric benzyl carbonate-derivatives
BAXTER INT0 citations47
ALBERTA RES COUNCIL
2 patentsUS5646123AJul 8, 1997
Time dependent administration of oligosaccharide glycosides related to blood group determinants having a type I or type II core structure in reducing inflammation in a sensitized mammal arising form exposure to an antigen
ALBERTA RES COUNCIL62 citations94
US5580858ADec 3, 1996
Immunosuppressive and tolerogenic modified Lewisx compounds
ALBERTA RES COUNCIL64 citations94